Abstract
Involvement of the pericardium in systemic sclerosis (SSc) is common, but rarely clinically apparent. Pericardial involvement consists of fibrinous pericarditis, pericardial adhesions, and acute or chronic pericarditis with or without effusion. Most pericardial effusions are small and asymptomatic, and are typically exudative; tamponade is rare. Patients typically present with dyspnea, chest pain, and fever.
Pleural disease in SSc is less common than parenchymal lung disease. Pleural effusions are uncommon, typically exudative, and are more likely to be found in patients with diffuse disease. Large or symptomatic pleural effusions due to SSc alone have not been described.
The principles of treatment for SSc-associated pleural and pericardial effusions include corticosteroids, ASA, NSAIDs, and colchicine, with evidence for methotrexate in chronic effusions.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Wooten MD, Reddy GV, Johnson RD. Cardiac tamponade in systemic sclerosis: a case report and review of 18 reported cases. J Clin Rheumatol. 2000;6:35–40.
Hosoya H, Derk CT. Clinically symptomatic pericardial effusions in hospitalized systemic sclerosis patients: demographics and management. Biomed Res Int. 2018;2018:6812082.
Nabatian S, Kantola R, Sabri N, Broy S, Lakier JB. Recurrent pericardial effusion and pericardial tamponade in a patient with limited systemic sclerosis. Rheumatol Int. 2007;27:759–61.
Desai CS, Lee DC, Shah SJ. Systemic sclerosis and the heart: current diagnosis and management. Curr Opin Rheumatol. 2011;23:545–54.
Kitchongcharoenying P, Foocharoen C, Mahakkanukrauh A, Suwannaroj S, Nanagara R. Pericardial fluid profiles of pericardial effusion in systemic sclerosis patients. Asian Pac J Allergy Immunol. 2013;31:314–9.
Satoh M, Tokuhira M, Hama N, et al. Massive pericardial effusion in scleroderma: a review of five cases. Br J Rheumatol. 1995;34:564–7.
Jaeger VK, Wirz EG, Allanore Y, et al. Incidences and risk factors of organ manifestations in the early course of systemic sclerosis: a longitudinal EUSTAR study. PLoS One. 2016;11:e0163894.
McWhorter JE, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med. 1974;57:566–75.
Leslie KO, Trahan S, Gruden J. Pulmonary pathology of the rheumatic diseases. Semin Respir Crit Care Med. 2007;28:369–78.
Thompson AE, Pope JE. A study of the frequency of pericardial and pleural effusions in scleroderma. Br J Rheumatol. 1998;37:1320–3.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2021 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Alyssa Sylvie Meilleur, S., Baron, M. (2021). Pericardial and Pleural Complications in Systemic Sclerosis. In: Matucci-Cerinic, M., Denton, C.P. (eds) Practical Management of Systemic Sclerosis in Clinical Practice. In Clinical Practice. Springer, Cham. https://doi.org/10.1007/978-3-030-53736-4_14
Download citation
DOI: https://doi.org/10.1007/978-3-030-53736-4_14
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-53735-7
Online ISBN: 978-3-030-53736-4
eBook Packages: MedicineMedicine (R0)